references
abegglen c, rosenstiel r, ort c, schärer m. weitergehende verfaren zur elimination von organischen spurenstoffen bei kommunalen abwasserreinigungsanlagen. varianten und kosten. korrespondenz abwasser, abfall 2009, 56:6, 584-592.
adas uk ltd 2010. impact of changing pesticide availability on horticulture. report for defra. http://randd.defra.gov.uk/document.aspx?document=if01100_10191_frp.pdf
amap 2009: persistent organic pollutants in the arctic. science of the total environment special issue. 408:2851-3051. elsevier, 2010
apoteket, 2006. environment and pharmaceuticals. published by apoteket ab (the national corporation of swedish pharmacies), stockholm county council and stockholm university.
burridge le, haya k, waddy sl, wade j, 2000. the lethality of anti-sea lice formulations salmosan® (azamethiphos) and excis® (cypermethrin) to stage iv and adult lobsters (homarus americanus) during repeated short-term exposures. aquaculture 182, 27-35.
cardinale bj. biodiversity improves water quality through niche partitioning. nature 2011, 472, 86-89.
cgedd, 2010. conseil général de l’environnement et du développement durable. médicament et environnement. la régulation du médicament vis-à-vis du risque environnemental. paris, november 2010.
chang h, wan y, wu s, fan z, hu j. occurrence of androgens and progestogens in wastewater treatment plants and receiving river waters: comparison to estrogens. water research 2011, 45, 732-740.
costa lg, giordano g. is decabromodiphenyl ether (bde-209) a developmental neurotoxicant? neurotoxicology 2011, 32, 9-24.
ecolas, 2005. assessing economic impacts of the specific control measures for priority substances and priority hazardous substances regulated under article 16 of the water framework directive. european commission dg env. july 2005. http://circa.europa.eu/public/irc/env/wfd/library?l=/framework_directive/thematic_documents /priority_substances/supporting_background/ecolas_reportpdf/_en_1.0_&a;=d
entec, 2011. substance impact reports. prepared to support this impact assessment. http://circa.europa.eu/public/irc/env/wfd/library?l=/framework_directive/thematic_documents /priority_substances/supporting_substances
entec, 2011b. methodology report. prepared to support this impact assessment. http://circa.europa.eu/public/irc/env/wfd/library?l=/framework_directive/thematic_documents /priority_substances/supporting_substances
european commission, 2006. impact assesssment of the thematic strategy on sustainable use of pesticides. sec(2006)894.


en
122
en




european commission, 2009. white paper - adapting to climate change: towards a european framework for action. com(2009)147 final.
european commission, 2009b. common implementation strategy for the water framework directive. guidance document on exemptions to the environmental objectives. http://circa.europa.eu/public/irc/env/wfd/library?l=/framework_directive/guidance_document s/documentn20_mars09pdf/_en_1.0_&a;=d
european commission, 2011. commission staff working paper sec(2011)1544. http://circa.europa.eu/public/irc/env/wfd/library?l=/framework_directive/thematic_documents /priority_substances/supporting_substances
european commission, 2011b. common implementation strategy for the water framework directive. technical guidance document for deriving environmental quality standards. http://circa.europa.eu/public/irc/env/wfd/library?l=/framework_directive/guidance_document s/tgd-eqs_cis-wfd/_en_1.0_&a;=d
european environment agency (eea), 2010. pharmaceuticals in the environment. eea technical report no. 1/2010.
eurostat, 2011. database env_watq2_1 annual water abstraction by source and by sector. http://appsso.eurostat.ec.europa.eu/nui/show.do?dataset=env_watq2_1〈=en
herbstman jb, sjödin a, kurzon m, lederman sa, jones rs, rauh v, needham ll, tang d, niedzwiecki m, wang ry, perera f. prenatal exposure to pbdes and neurodevelopment.
environmental health perspectives 2010, 118:5, 712-9.
hgca 2009. pesticide availability for cereals and oilseeds following revision of directive 91/414/eec; effects of losses and new research priorities.
inotai a, hankó b, mészáros a, 2010 trends in the non-steroidal anti-inflammatory drug market in six central-eastern european countries based on retail information. pharmacoepidemiol drug saf. 19(2) 183-90. http://www.ncbi.nlm.nih.gov/pubmed/20014174
jrc, 2011. estimation of the value of natural nitrogen removal in rivers and lakes. in preparation.
kidd ka, blanchfield pj, mills kh, palace vp, evans re, lazorchak jm, flick rw. collapse of a fish population after exposure to a synthetic estrogen. proceedings of the national academy of sciences 2007, 104:21, 8897-8901.
knappe, 2008. kampa e, vidaurre r. deliverable 3.3. identification of options for the design of future instruments to limit pollution from pharmaceutical products into water.
lepper p, 2005. manual on the methodological framework to derive environmental quality standards for priority substances in accordance with article 16 of the water framework directive (2000/60/ec).
roig b, 2010. pharmaceuticals in the environment: current knowledge and need assessment to reduce presence and impact. edited by benoit roig. isbn: 9781843393146. published by iwa publishing, london, uk.


en
123
en




scher (scientific committee on health and environmental risks), opinion on chemicals and the water framework directive: technical guidance for deriving environmental quality standards, october 2010. http://ec.europa.eu/health/scientific_committees/environmental_risks/docs/scher_o_127.pdf
sctee (scientific committee on toxicity, ecotoxicity and the environment), opinion on the setting of environmental quality standards for the priority substances included in annex x of directive 2000/60/ec in accordance with article 16 thereof. adopted during the 43rd plenary meeting of 28 may 2004. http://ec.europa.eu/health/archive/ph_risk/committees/sct/documents/out230_en.pdf
sednet, 2004. european sediment research network. contaminated sediments in european river basins. http://www.sednet.org
sru, 2007. german advisory council on the environment. statement nb. 12, april 2007. pharmaceuticals in the environment. http://www.umweltrat.de/shareddocs/downloads/en/04_statements/2007_statement_12_ph armaceuticals_environment.pdf?__blob=publicationfile
sundseth k, pacyna jm, pacyna eg, munthe j, belhaj m, astrom s. economic benefits from decreased mercury emissions: projections for 2020. journal of cleaner production 2010, 18, 386-394.
swedish medical products agency, 2009. sustainable development and pharmaceuticals. post conference booklet. 10-11 november.


en
124
en





